Deep Bio and PathAI Collaborate to Drive AI-Powered Innovations in Digital Pathology
recent articles
SEOUL, SOUTH KOREA, August 6, 2024 /EINPresswire.com/ -- Deep Bio Inc., a leader in AI-driven digital pathology solutions, announced the publication of an external validation study for its DeepDx Prostate AI algorithm, conducted by Stanford...
Fimlab Laboratories Ltd has selected Aiforia Technologies Plc as the provider for breast and prostate cancer diagnostics solutions. Aiforia Technologies Plc, August 1, 2024 at 09:00 am EEST -- Fimlab Laboratories Ltd has selected Aiforia...
Welcome to PathPulse: Pathology Innovators in Action, your go-to podcast for practical and implemented digital pathology insights and solutions. This podcast is sponsored by the Digital Diagnostic Summit and Lumea. In our inaugural episode,...
From the Motic blog: As digital pathology is more widely adopted, the demand for a smoother user experience is increasing. While we have a variety of state-of-the-art instruments on the market, scanning every possible modality and variety of...
Proscia will host product webinar in September. Concentriq AP: A New Era of AI in Pathology September 17, 12:00 PM — 12:45 PM EDT Register Secure your spot and be part of the conversation that’s shaping the future of precision...
Paige: The newly open-sourced foundation models accelerate cancer innovation with unprecedented access to the most trusted and advanced AI technology available today NEW YORK August 01, 2024 --(BUSINESS WIRE)--Paige, a pioneer in AI-driven...
